cefoxitin and Adnexal-Diseases

cefoxitin has been researched along with Adnexal-Diseases* in 1 studies

Other Studies

1 other study(ies) available for cefoxitin and Adnexal-Diseases

Article	Year
[Laboratory and clinical studies on cefoxitin in the field of obstetrics and gynecology (author's transl)]. The Japanese journal of antibiotics, 1978, Volume: 31, Issue:6 1) Serum concentrations of cefoxitin (CFX) was lower than that of cefazolin (CEZ), but the tissue concentrations of CFX were higher in ovary, oviduct and uterus compared with CEZ. 2) CFX was administered to 15 patients with moderate intrapelvic or urinary tract infections at a dose of 4 g per day for 5 to 7 days. The overall results obtained were as follows; excellent in 6 cases, good in 6 cases. The CFX treatment was effective in all patients, 8 cases, with intrapelvic infections. 3) The majority of organisms detected were E. coli (12 strains), and the antimicrobial activity of CFX against them was superior to those of CEZ and CET. 4) No side effects and abnormal laboratory findings were observed. 5) It is considered that CFX will be a useful drug in the field of obstetrics and gynecology. Topics: Adnexal Diseases; Adult; Cefazolin; Cefoxitin; Cephalosporins; Escherichia coli; Fallopian Tubes; Female; Humans; Leiomyoma; Middle Aged; Myometrium; Ovary; Urinary Tract Infections; Uterine Neoplasms	1978

Article

Year

[Laboratory and clinical studies on cefoxitin in the field of obstetrics and gynecology (author's transl)].

The Japanese journal of antibiotics, 1978, Volume: 31, Issue:6

1) Serum concentrations of cefoxitin (CFX) was lower than that of cefazolin (CEZ), but the tissue concentrations of CFX were higher in ovary, oviduct and uterus compared with CEZ. 2) CFX was administered to 15 patients with moderate intrapelvic or urinary tract infections at a dose of 4 g per day for 5 to 7 days. The overall results obtained were as follows; excellent in 6 cases, good in 6 cases. The CFX treatment was effective in all patients, 8 cases, with intrapelvic infections. 3) The majority of organisms detected were E. coli (12 strains), and the antimicrobial activity of CFX against them was superior to those of CEZ and CET. 4) No side effects and abnormal laboratory findings were observed. 5) It is considered that CFX will be a useful drug in the field of obstetrics and gynecology.

Topics: Adnexal Diseases; Adult; Cefazolin; Cefoxitin; Cephalosporins; Escherichia coli; Fallopian Tubes; Female; Humans; Leiomyoma; Middle Aged; Myometrium; Ovary; Urinary Tract Infections; Uterine Neoplasms

1978